Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Accelerates Growth With AI Collaboration And Strong Q1 Momentum
![]() |
Short-term technicals signal modest bullish pressure while fundamentals show robust revenue expansion but rich valuation metrics that constrain upside. Liquidity and revenue momentum support operational flexibility even as valuation exceeds peer norms. |








